Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

It's Bloody Halloween!

A Ghoulish Update

Heidi James, MD and Andrew Buelt, DO
00:00
12:13
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Tags cardiovascular · oncology · pharmacology · screening

Andrew and Heidi talk about the potential role of ASA in preventing colorectal cancer, compare fracture risks associated with common anticoagulants, and go on a bit of a tirade about lung cancer screening.

 

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

Fredrik H. -

Hello, I did not know about the fracture risc with warfarin treatment. Could you give me the reference please for the paper from Jan 2017?

Heidi J., MD -

Interesting fact, heh? Here's the reference

Sugiyama, Toshihiro. "Osteoporotic Fractures Associated With Dabigatran vs Warfarin." Jama 318.1 (2017): 90-91.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
It's Bloody Halloween! Full episode audio for MD edition 187:22 min - 88 MB - M4AHippo Primary Care RAP - October 2017 Summary 2 MB - PDF